• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Functional connectivity similar between autosomal dominant and late onset Alzheimer Disease

byAshley AaroeandJames Jiang
July 29, 2014
in Chronic Disease, Imaging and Intervention, Neurology
Reading Time: 3 mins read
2 Minute Medicine Rewind December 31-January 6, 2013
Share on FacebookShare on Twitter

1. Functional MRI images change in similar ways during the progression of both late-onset Alzheimer disease and autosomal dominant (inherited) Alzheimer disease. 

2. This study suggests that functional MRI images may be useful in research of treatments for Alzheimer disease, and that study of the autosomal dominant form may provide insight into the mechanisms underlying the late-onset form. 

Evidence Rating Level: 2 (Good) 

Study Rundown: Alzheimer disease is the most common cause of dementia, and while the majority of cases of Alzheimer disease is caused by a combination of genetic and environmental factors, a specific subtype of Alzheimer disease is known to be caused by certain mutations which result in autosomal dominant Alzheimer disease (ADAD), which presents earlier in life than the more common ‘late-onset Alzheimer disease’ (LOAD). This study sought to evaluate disease progression through a modality called resting-state functional connectivity magnetic resonance imaging (rs-fcMRI), which compares the strength of an oxygen-dependent signal between brain areas that interact and network with each other.

This study found similarities on rs-fcMRI changes between ADAD and LOAD. This modality could therefore be used as an end-point to assess the efficacy of potential interventions for both disease states. The similarity of imagining findings also suggests that ADAD may be similar enough to LOAD to provide a basis for further investigation of the pathogenesis of LOAD.  In general, this study was limited by slightly different scanning techniques used between the ADAD and LOAD cohorts. The authors claim that despite these differences they were able to effectively demonstrate similarities between ADAD and LOAD. The older age of LOAD patients may present a confounding variable, although the study attempted to adjust for age differences between the two cohorts.

Click to read the study, published today in JAMA Neurology

RELATED REPORTS

The Scan by 2 Minute Medicine®: popular joint supplement raises Alzheimer’s red flags, the gut health industry is outrunning the science, chronic wasting disease is spreading silently and scientists are watching closely, and the oral GLP-1 pill era begins with Foundayo

The Scan by 2 Minute Medicine®: Versatile Ozempic, Healthcare Reform, Unlocking the Brain, and Chickens and the Next Pandemic:

Caregivers of people with dementia may benefit from online decision aid when managing firearm access

Relevant Reading: Dominantly Inherited Alzheimer Network. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease

In-Depth [cross-sectional cohort]: Data regarding a group of patients with ADAD was obtained via the international Dominantly Inherited Alzheimer Network, and patients at risk for LOAD were studied based on data from the Knight Alzheimer Disease Research Center at Washington University in St. Louis. The demographics of these cohorts were compared using independent linear mixed models, revealing a significant difference in age between patients with ADAD (mean ages for different disease severities were between 30.9-49.4 years old) and LOAD (68.7-70.1 years old). Experienced clinicians were asked to assess patients using a structured rating scale called the Clinical Dementia Rating (CDR). Apolipoprotein E Ɛ4 allele status was determined using peripheral blood.

Rs-fcMRI was performed, and Blood-Oxygen-Level Dependent (BOLD) signal data was extracted for thirty-five brain regions, called resting state networks (RSNs), including areas implicated in Alzheimer disease related functional decline. The results indicate that a worsening Clinical Dementia Rating (CDR) score was associated with a decrease in functional connectivity as assessed by rs-fcMRI in both ADAD and LOAD in multiple RSNs. Both ADAD and LOAD showed similar functional connectivity changes with respect to CDR. An ordinal logistic regression model in ADAD was able to predict LOAD CDR scores much better than chance (P<0.001). However, the CDR effect was greater in ADAD as compared to LOAD in several RSNs.

Image: PD 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: Alzheimer’s disease
Previous Post

Vitamin D not effective in reducing recurrent bacterial vaginosis

Next Post

Ezetimibe (Zetia, Vytorin) use declining after ENHANCE trial publication in 2008

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Chronic Disease

The Scan by 2 Minute Medicine®: popular joint supplement raises Alzheimer’s red flags, the gut health industry is outrunning the science, chronic wasting disease is spreading silently and scientists are watching closely, and the oral GLP-1 pill era begins with Foundayo

July 9, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Versatile Ozempic, Healthcare Reform, Unlocking the Brain, and Chickens and the Next Pandemic:

January 7, 2025
Public Health

Caregivers of people with dementia may benefit from online decision aid when managing firearm access

October 22, 2024
Neurology

High-sugar dietary pattern associated with increased risk of dementia

July 25, 2024
Next Post
Low circulating cholesterol in neonates linked with pyloric stenosis

Ezetimibe (Zetia, Vytorin) use declining after ENHANCE trial publication in 2008

Prophylactic platelet transfusions prevent bleeding in hematologic cancers

Blood cell folate concentration may accurately predict neural tube defects

Insecticidal bed nets linked with reduced transmission of lymphatic filariasis

Novel malaria drug clears parasitemia in phase 2 study

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
  • Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.